share_log

Truist Securities Maintains Buy on Affimed, Lowers Price Target to $6

Benzinga ·  Aug 11, 2023 10:09

Truist Securities analyst Srikripa Devarakonda maintains Affimed (NASDAQ:AFMD) with a Buy and lowers the price target from $8 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment